Metrics as of 10/13/2026, 06:54 PM (Berlin time), refresh in progress.
Tristel PLC
Tristel plc is a company specializing in the creation, production, and global distribution of products designed to prevent infections, serving both its home market in the UK and international clients. Its operations are structured around three core divisions: the decontamination of medical devices within hospital…
1D
+0.1%
1W
+2.1%
1M
+11.2%
6M
+14.8%
YTD
+4.5%
1Y
+20.9%
2Y
+19.6%
5Y
-15.8%
10Y
+172.7%
Next earnings date
19/10/2026 (in 2 days)
Volatility around earnings
~46% stronger price swings than usual
P/E
26.48
P/B
6.21
EV/EBITDA
17.39
RETURN ON EQUITY
11.8%
NET MARGIN
15.4%
DEBT/EQUITY
0.17
DIVIDEND YIELD
3.3%
AS OF
31/12/2025
FREE FLOAT
96.0%
FLOAT SHARES
46,100,174
AVG. DAILY VOLUME (30D)
67,466
Tristel PLC is a company in the Healthcare sector, Medical - Instruments & Supplies industry, headquartered in United Kingdom.
The CEO is Christopher Paul Lee, the company employs around 270 people.
The IPO was on 01/06/2005; the stock trades on LSE under the ticker TSTL.L.
The next earnings date is 19/10/2026.
Around past earnings, price swings were roughly 46% stronger than usual.
Yes. The last dividend was £5.68 per share, ex-date 19/03/2026, paid on 09/04/2026.
The dividend yield is 3.3% (as of 31/12/2025).
Comparable stocks include ConvaTec Group, Intuitive Surgical, Becton, Dickinson and Company, ResMed, West Pharmaceutical Services, Sartorius, Solventum and Baxter International.
Clicking "Analyze stock" lets five strategies assess Tristel against fixed, published rules and judge it bullish, neutral or bearish. The jury states where it disagrees. A free account starts with 5 credits, a quick check costs 1 credit, a full analysis 2 credits.
Not investment advice. Past performance is not an indicator of future results.